As of Mar 19
| -0.41 / -3.42%|
The 8 analysts offering 12-month price forecasts for Cross Country Healthcare Inc have a median target of 16.50, with a high estimate of 19.00 and a low estimate of 13.00. The median estimate represents a +42.49% increase from the last price of 11.58.
The current consensus among 9 polled investment analysts is to Buy stock in Cross Country Healthcare Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.